Sara Elis Bianchi
Universidade Federal do Rio Grande do Sul
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sara Elis Bianchi.
Journal of Chromatography B | 2016
Sara Elis Bianchi; Helder Ferreira Teixeira; Samuel Kaiser; George González Ortega; Paulo H. Schneider; Valquiria Linck Bassani
Coumestrol is present in several species of the Fabaceae family widely distributed in plants. The estrogenic and antioxidant activities of this molecule show its potential as skin anti-aging agent. These characteristics reveal the interest in developing analytical methodology for permeation studies, as well as to know the stability of coumestrol identifying the major degradation products. Thus, the present study was designed, first, to develop and validate a versatile liquid chromatography (HPLC) method to quantify coumestrol in a hydrogel formulation in different porcine skin layers (stratum corneum, epidermis, and dermis) in permeation tests. In the stability-indicating test coumestrol samples were exposed to stress conditions: temperature, UVC light, oxidative, acid and alkaline media. The degradation products, as well as the constituents extracted from the hydrogel, adhesive tape or skin were not eluted in the retention time of the coumestrol. Hence, the HPLC method showed to be versatile, specific, accurate, precise and robust showing excellent performance for quantifying coumestrol in complex matrices involving skin permeation studies. Coumestrol recovery from porcine ear skin was found to be in the range of 97.07-107.28 μg/mL; the intra-day precision (repeatability) and intermediate precision (inter-day precision), respectively lower than 4.71% and 2.09%. The analysis using ultra-performance liquid chromatography coupled to a quadrupole time-of-flight high definition mass spectrometry detector (UPLC-QTOF/HDMS) suggest the MS fragmentation patterns and the chemical structure of the main degradation products. These results represent new and relevant findings for the development of coumestrol pharmaceutical and cosmetic products.
British Journal of Pharmacology | 2017
Denise dos Santos Lacerda; Patrick Turck; Bruna Gazzi de Lima-Seolin; Rafael Colombo; Vanessa Duarte Ortiz; Jéssica Hellen Poletto Bonetto; Cristina Campos-Carraro; Sara Elis Bianchi; Adriane Belló-Klein; Valquiria Linck Bassani; Alex Sander da Rosa Araujo
In cor pulmonale, the increased afterload imposed on the right ventricle (RV) generates a maladaptive response, impairing the contractile cardiac function. Oxidative mechanisms play an important role in the pathophysiology and progression of this disease. The administration of pterostilbene (PTS), a phytophenol with antioxidant potential, may represent a therapeutic option. In the present study, we evaluated the effect of PTS complexed with hydroxypropyl‐β‐cyclodextrin (HPβCD) on hypertrophy, contractile function and oxidative parameters in the RV of rats with pulmonary hypertension, induced by the administration of monocrotaline (MCT).
Medicinal Chemistry Research | 2018
Denise dos Santos Lacerda; Sara Elis Bianchi; Wesley L. Pinós; Cristina Campos-Carraro; Patrick Turck; Alexandre Roberto Hickmann; Vanessa Pittol; Rayane Brinck Teixeira; Adriane Belló-Klein; Valquiria Linck Bassani; Alex Sander da Rosa Araujo
The objectives of this study were to promote the aqueous solubility of pterostilbene (PTS) by complexation with hydroxypropyl-β-cyclodextrin (HPβCD), characterize the complex under physical aspects, to make its oral administration feasible in biological tests, and to investigate their pharmacological properties. For 14 days, rats received daily PTS:HPΒCD complex at doses of 25, 50, or 100 mg kg−1 per day orally. The results showed no kidney or liver damage, nor any induction of apoptosis by the administered doses. Also, the complex showed dose-dependent antioxidant effects in the rat liver, as evidenced by a reduction in lipid peroxidation and reactive oxygen species, as well as an increase in non-enzymatic antioxidant. PTS:HPΒCD complex also increased the expression of sensitive redox proteins such as AKT and GSK-3β related to the insulin signaling pathway in the liver. Thus, the complexation demonstrated to be able to increase the apparent solubility of PTS making feasible dose curve administration and could be a food alternative complementary to antioxidant therapeutic. Therefore, the PTS:HPβCD complex can be used for prevention of diseases related to oxidative damage and insulin signaling.
Journal of Pharmacy and Pharmacology | 2018
Paula Hollweg Dias; Marina Scopel; Simony Martiny; Sara Elis Bianchi; Valquiria Linck Bassani; Jose Angelo Silveira Zuanazzi
This study was aimed to investigate the in vitro permeation potential of hydrogel formulations containing the isoflavones formononetin and biochanin A and cyclodextrins in different combinations.
Free Radical Research | 2018
Denise dos Santos Lacerda; Vanessa Duarte Ortiz; Patrick Turck; Cristina Campos-Carraro; Alexsandra Zimmer; Rayane Brinck Teixeira; Sara Elis Bianchi; Alexandre Luz de Castro; Paulo Cavalheiro Schenkel; Adriane Belló-Klein; Valquiria Linck Bassani; Alex Sander da Rosa Araujo
Abstract Oxidative stress alters signalling pathways for survival and cell death favouring the adverse remodelling of postmyocardial remnant cardiomyocytes, promoting functional impairment. The administration of pterostilbene (PTS), a phytophenol with antioxidant potential, can promote cardioprotection and represents a therapeutic alternative in acute myocardial infarction (AMI). The present study aims to explore the effects of oral administration of PTS complexed with hydroxypropyl-β-cyclodextrin HPβCD (PTS:HPβCD complex) on the glutathione cycle, thiol protein activities and signalling pathways involving the protein kinase B (AKT) and glycogen synthase kinase-3β (GSK-3β) proteins in the left ventricle (LV) of infarcted rats. Animals were submitted to acute myocardial infarction through surgical ligation of the descending anterior branch of the left coronary artery and received over 8 days, by gavage, PTS:HPβCD complex at dose of 100 mg kg−1 day−1 (AMI + PTS group) or vehicle (aqueous solution with HPβCD) divided into Sham-operated (SHAM) and infarcted (AMI) groups. The results showed that the PBS: HPβCD complex decreased lipid peroxidation, prevented the decrease in thioredoxin reductase (TRxR) activity, and increased the activity of glutathione-S-transferase (GST) and glutaredoxin (GRx). Additionally, the expression of nuclear factor-erythroid two (Nrf2) and p-GSK-3β was increased, whereas the p-GSK-3β/GSK-3β ratio was reduced in the LV of the infarcted animals. Overall, the PTS:HPβCD complex modulates activity of thiol-dependent enzymes and induces to the expression of antioxidant proteins, improving systolic function and mitigating the adverse cardiac remodelling post infarction.
European Journal of Pharmaceutical Sciences | 2018
Sara Elis Bianchi; Barbara E.K. Machado; Marília G.C. da Silva; Michelle Maidana da Silva; Lidiane Dal Bosco; Magno da Silva Marques; Ana Paula Horn; Lara Persich; Fabiana Cristina Geller; Débora Fretes Argenta; Helder Ferreira Teixeira; Cláudia Maria Oliveira Simões; Cristiana Lima Dora; Valquiria Linck Bassani
ABSTRACT Several beneficial effects on the skin have been reported for coumestrol (COU), such as protection against photoaging and improvement of skin elasticity and thickness in postmenopausal women. However no reports on the effect of COU on wound healing were found. Nevertheless, COU has low aqueous solubility, which is a crucial limitation for biological tests. The present study was designed as a two‐step experiment to evaluate the wound healing effect of COU. First, we used fibroblasts and the experimental in vitro artificial wound model, scratch assay, to compare the effects of COU free, dissolved in dimethyl sulfoxide (DMSO) or Dulbeccos modified Eagles medium (DMEM), or associated with hydroxypropyl‐&bgr;‐cyclodextrin (HP&bgr;CD). The 50&mgr;M (66.1%) and 10&mgr;M (56.3%) COU/HP&bgr;CD association induced cell proliferation and migration in inflicted wounds. Subsequently, the in vivo wound healing experimental model (Wistar rats) revealed that COU/HP&bgr;CD incorporated into hypromellose (HPMC) hydrogel had similar efficacy in wound healing in comparison to the positive control (Dersani®), with the advantage that 50% wound healing was achieved within a shorter period. In summary, the results successfully demonstrated, for the first time, the wound healing effect of COU/HP&bgr;CD incorporated into HPMC hydrogel and describe the feasibility of the biological tests with the use of HP&bgr;CD instead DMSO.
Toxicology in Vitro | 2018
Priscila Oliveira de Souza; Sara Elis Bianchi; Fabrício Figueiró; Luana Heimfarth; Karla Suzana Moresco; Rosângela Mayer Gonçalves; Juliana Bender Hoppe; Caroline Peres Klein; Christianne Gazzana Salbego; Daniel Pens Gelain; Valquiria Linck Bassani; Alfeu Zanotto Filho; José Cláudio Fonseca Moreira
Archive | 2017
Schauana Freitas Fraga; Denise dos Santos Lacerda; Vanessa Ortiz da Rocha Araújo; Patrick Turck; Cristina Campos Carraro; Rayane Brinck Teixeira; Sara Elis Bianchi; Adriane Belló-Klein; Valquiria Linck Bassani; Alex Sander da Rosa Araújo
Archive | 2017
Denise dos Santos Lacerda; Patrick Turck; Cristina Campos Carraro; Alexandre Roberto Hickmann; Sara Elis Bianchi; Adriane Belló-Klein; Valquiria Linck Bassani; Alex Sander da Rosa Araújo
Archive | 2017
Schauana Freitas Fraga; Denise dos Santos Lacerda; Vanessa Duarte Ortiz; Patrick Turck; Cristina Campos Carraro; Alexandre Roberto Hickmann; Rayane Brinck Teixeira; Sara Elis Bianchi; Alexandre Luz de Castro; Adriane Belló-Klein; Valquiria Linck Bassani; Alex Sander da Rosa Araújo